Interferon epsilon and ovarian cancer.

Elorbany, Samar; Malacrida, Beatrice; Balkwill, Frances

Elorbany, Samar; Malacrida, Beatrice; Balkwill, Frances.

Afiliação

Elorbany S; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London, UK.
Malacrida B; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London, UK.
Balkwill F; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London, UK. Electronic address: f.balkwill@qmul.ac.uk.

Trends Cancer ; 9(12): 985-986, 2023 12.

Article em En | MEDLINE | ID: mdl-37778961

ABSTRACT

ABSTRACT

Most biologists know of the interferons IFNα, IFNß, and IFNÎ³ and their roles in immunity and infection, but they may not have heard of IFNÎµ. A recent study in Nature suggests that IFNÎµ can act as a tumor suppressor in serous ovarian cancers.

Assuntos

Interferons; Neoplasias Ovarianas; Feminino; Humanos; Neoplasias Ovarianas/imunologia; Interferons/metabolismo

Palavras-chave

interferon; interferon epsilon; ovarian cancer; tumor suppressor; type I interferon

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Interferons Limite: Female / Humans Idioma: En Revista: Trends Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google